Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arena Pharmaceuticals (NQ: ARNA ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Arena Pharmaceuticals < Previous 1 2 3 Next > NeurAxis: Should You Buy This IPO? February 08, 2023 As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype. Via Talk Markets NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution February 06, 2023 As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio. Via Talk Markets Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price March 10, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Arena Pharmaceuticals Inc. (NASDAQ: ARNA... Via Benzinga 7 Biotech Stocks With Key Catalysts in March March 09, 2022 These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. Via InvestorPlace Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers March 08, 2022 GAINERS: Nine Energy Service (NYSE: Via Benzinga Expert Ratings For Arena Pharmaceuticals February 09, 2022 Arena Pharmaceuticals (NASDAQ:ARNA) has observed the following analyst ratings within the last quarter: Via Benzinga Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000 March 08, 2022 Futures rebounded from yesterday huge loss, and after touching a session low of 4,138, S&P futures bounced shortly after the European when Bloomberg reported that the European Union was set to reveal a... Via Talk Markets Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY February 24, 2022 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) revealed Wednesd... Via Benzinga Arena Pharmaceuticals: Q4 Earnings Insights February 23, 2022 Arena Pharmaceuticals (NASDAQ:ARNA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... Via Benzinga The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development February 23, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... Via Benzinga The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow February 20, 2022 Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022 February 09, 2022 Upgrades According to Capital One, the prior rating for Federal Realty Investment Trust (NYSE:FRT) was changed from Equal-Weight to Overweight. Federal Realty Investment... Via Benzinga 7 Long-Term Stocks to Buy and Hold Until 2030 January 17, 2022 Long-term stocks that promise to be value creators with a robust business model and positive industry tailwinds. Companies that are positioned for robust free cash flows. Via InvestorPlace 10 Biggest Price Target Changes For Tuesday December 21, 2021 B of A Securities lifted the price target on Micron Technology, Inc. (NASDAQ: Via Benzinga Benzinga's Bulls And Bears Of The Past Week: Pfizer, Bank Of America, Beyond Meat, GameStop, AMC, Overstock And More December 18, 2021 Benzinga has examined the prospects for many investor favorite stocks over the... Via Benzinga The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More December 17, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021 December 14, 2021 Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE: Via Benzinga What 6 Analyst Ratings Have To Say About Arena Pharmaceuticals December 14, 2021 Over the past 3 months, 6 analysts have published their opinion on Arena Pharmaceuticals (NASDAQ: Via Benzinga 10 Biggest Price Target Changes For Tuesday December 14, 2021 B of A Securities lifted the price target on Apple Inc. (NASDAQ: AAPL) from $160 to $210. Apple shares rose 0.4% to $176.37 in pre-market trading. JP Morgan lowered Zscaler,... Via Benzinga 58 Biggest Movers From Yesterday December 14, 2021 Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-... Via Benzinga Vaccine Stocks Get A Booster As U.K. Plans Third Jab For All December 13, 2021 Covid vaccine stocks jumped Monday on worries that the omicron variant of the virus could soon overwhelm the United Kingdom. Via Investor's Business Daily Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher December 13, 2021 Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47. The U.S. has... Via Benzinga Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge December 13, 2021 Midway through trading Monday, the Dow traded down 0.81% to 35,679.10 while the NASDAQ fell 0.78% to 15,509.01. The S&P also fell, dropping 0.67% to 4,680.56. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 40 Stocks Moving In Monday's Mid-Day Session December 13, 2021 Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session December 13, 2021 Gainers Arena Pharmaceuticals (NASDAQ:ARNA... Via Benzinga AMC, GME: What Investors Are Saying as the Top 2 Meme Stocks Tumble Today December 13, 2021 AMC Entertainment (AMC) and GameStop (GME) are taking a beating today and traders of the meme stocks are reacting on social media. Via InvestorPlace GPRO Stock Price Prediction: Why One Analyst Is Raising Its GoPro Target December 13, 2021 GoPro (GPRO) stock is rising higher on Monday thanks to a new upgrade and price prediction from Wedbush analyst Alicia Reese. Via InvestorPlace How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal December 13, 2021 The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash... Via Talk Markets Topics Cannabis Exposures Cannabis ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today December 13, 2021 Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE). Via InvestorPlace How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal December 13, 2021 Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e... Via Benzinga Topics Cannabis Exposures Cannabis < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
